{"transactions":[{"id":739060,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T18:37:40.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the \"Plan\") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan)."}],"balance_after":6500,"derivative":{"exercise_price":7.93,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001791742-26-000002","document":"wk-form4_1781289457.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789769/000179174226000002/wk-form4_1781289457.xml","form_type":"4"}},{"id":874317,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Science & Tech."}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T00:26:00.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option shall vest and become exercisable on March 1, 2027, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date."}],"balance_after":225000,"derivative":{"exercise_price":3.3,"expiration_date":"2036-03-01","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001193125-26-086135","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000119312526086135/ownership.xml","form_type":"4"}},{"id":934309,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Science & Tech."}}],"security":"Common Stock","published_at":"2026-01-21T23:56:30.000Z","date":"2026-01-21","kind":"purchase","planned":false,"acquired":true,"shares":11312,"price":2.1891,"value":24763.0992,"ownership":{"direct":true},"balance_after":31312,"source":{"system":"sec-edgar","filing":"0001193125-26-018325","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000119312526018325/ownership.xml","form_type":"4"}},{"id":1130169,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-29T23:13:10.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 substantially equal monthly installments commencing on June 28, 2025, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the \"Plan\") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan)."}],"balance_after":6500,"derivative":{"exercise_price":26.75,"expiration_date":"2035-05-27","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001789769-25-000070","document":"wk-form4_1748560384.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789769/000178976925000070/wk-form4_1748560384.xml","form_type":"4"}},{"id":1142840,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Science & Tech."}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:38.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $1.92 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date.  Under the terms of the stock option award repricing, a repriced stock option award will revert to its original exercise price if exercised during the Retention Period. The \"Retention Period\", through which the Reporting Person must remain in service to the Issuer, commenced on the Repricing Date and ends upon the earliest of (i) the one-year anniversary of the Repricing Date, (ii) a Sale Event (as defined in the 2018 Plan and 2019 Plan, as applicable) and (iii) the termination of the Reporting Person's Service Relationship (as defined in the 2018 Plan and 2019 Plan, as applicable) due to the Reporting Person's death or disability."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":130000,"derivative":{"exercise_price":1.92,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0000950170-25-074816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074816/ownership.xml","form_type":"4"}},{"id":1142839,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Science & Tech."}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:38.000Z","date":"2025-05-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":23.97,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0000950170-25-074816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074816/ownership.xml","form_type":"4"}},{"id":1142838,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Science & Tech."}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:38.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":176000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $1.92 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date.  Under the terms of the stock option award repricing, a repriced stock option award will revert to its original exercise price if exercised during the Retention Period. The \"Retention Period\", through which the Reporting Person must remain in service to the Issuer, commenced on the Repricing Date and ends upon the earliest of (i) the one-year anniversary of the Repricing Date, (ii) a Sale Event (as defined in the 2018 Plan and 2019 Plan, as applicable) and (iii) the termination of the Reporting Person's Service Relationship (as defined in the 2018 Plan and 2019 Plan, as applicable) due to the Reporting Person's death or disability."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":176000,"derivative":{"exercise_price":1.92,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":176000},"source":{"system":"sec-edgar","filing":"0000950170-25-074816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074816/ownership.xml","form_type":"4"}},{"id":1142837,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Science & Tech."}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:38.000Z","date":"2025-05-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":176000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":11.09,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":176000},"source":{"system":"sec-edgar","filing":"0000950170-25-074816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074816/ownership.xml","form_type":"4"}},{"id":1142836,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Science & Tech."}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:38.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $1.92 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date.  Under the terms of the stock option award repricing, a repriced stock option award will revert to its original exercise price if exercised during the Retention Period. The \"Retention Period\", through which the Reporting Person must remain in service to the Issuer, commenced on the Repricing Date and ends upon the earliest of (i) the one-year anniversary of the Repricing Date, (ii) a Sale Event (as defined in the 2018 Plan and 2019 Plan, as applicable) and (iii) the termination of the Reporting Person's Service Relationship (as defined in the 2018 Plan and 2019 Plan, as applicable) due to the Reporting Person's death or disability."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":160000,"derivative":{"exercise_price":1.92,"expiration_date":"2032-01-17","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0000950170-25-074816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074816/ownership.xml","form_type":"4"}},{"id":1142835,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Science & Tech."}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:38.000Z","date":"2025-05-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.21,"expiration_date":"2032-01-17","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0000950170-25-074816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074816/ownership.xml","form_type":"4"}},{"id":1142834,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Science & Tech."}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:38.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $1.92 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date.  Under the terms of the stock option award repricing, a repriced stock option award will revert to its original exercise price if exercised during the Retention Period. The \"Retention Period\", through which the Reporting Person must remain in service to the Issuer, commenced on the Repricing Date and ends upon the earliest of (i) the one-year anniversary of the Repricing Date, (ii) a Sale Event (as defined in the 2018 Plan and 2019 Plan, as applicable) and (iii) the termination of the Reporting Person's Service Relationship (as defined in the 2018 Plan and 2019 Plan, as applicable) due to the Reporting Person's death or disability."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":125000,"derivative":{"exercise_price":1.92,"expiration_date":"2031-02-28","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-25-074816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074816/ownership.xml","form_type":"4"}},{"id":1142833,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Science & Tech."}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:38.000Z","date":"2025-05-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":11.47,"expiration_date":"2031-02-28","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-25-074816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074816/ownership.xml","form_type":"4"}},{"id":1142832,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Science & Tech."}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:38.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":29908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $1.92 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date.  Under the terms of the stock option award repricing, a repriced stock option award will revert to its original exercise price if exercised during the Retention Period. The \"Retention Period\", through which the Reporting Person must remain in service to the Issuer, commenced on the Repricing Date and ends upon the earliest of (i) the one-year anniversary of the Repricing Date, (ii) a Sale Event (as defined in the 2018 Plan and 2019 Plan, as applicable) and (iii) the termination of the Reporting Person's Service Relationship (as defined in the 2018 Plan and 2019 Plan, as applicable) due to the Reporting Person's death or disability."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":29908,"derivative":{"exercise_price":1.92,"expiration_date":"2029-10-23","underlying":"Common Stock","underlying_shares":29908},"source":{"system":"sec-edgar","filing":"0000950170-25-074816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074816/ownership.xml","form_type":"4"}},{"id":1142831,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Science & Tech."}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:38.000Z","date":"2025-05-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":29908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":11,"expiration_date":"2029-10-23","underlying":"Common Stock","underlying_shares":29908},"source":{"system":"sec-edgar","filing":"0000950170-25-074816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074816/ownership.xml","form_type":"4"}},{"id":1142830,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Science & Tech."}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:38.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":66667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $1.92 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date.  Under the terms of the stock option award repricing, a repriced stock option award will revert to its original exercise price if exercised during the Retention Period. The \"Retention Period\", through which the Reporting Person must remain in service to the Issuer, commenced on the Repricing Date and ends upon the earliest of (i) the one-year anniversary of the Repricing Date, (ii) a Sale Event (as defined in the 2018 Plan and 2019 Plan, as applicable) and (iii) the termination of the Reporting Person's Service Relationship (as defined in the 2018 Plan and 2019 Plan, as applicable) due to the Reporting Person's death or disability."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":66667,"derivative":{"exercise_price":1.92,"expiration_date":"2029-08-21","underlying":"Common Stock","underlying_shares":66667},"source":{"system":"sec-edgar","filing":"0000950170-25-074816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074816/ownership.xml","form_type":"4"}},{"id":1142829,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Science & Tech."}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:38.000Z","date":"2025-05-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":66667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":9.54,"expiration_date":"2029-08-21","underlying":"Common Stock","underlying_shares":66667},"source":{"system":"sec-edgar","filing":"0000950170-25-074816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074816/ownership.xml","form_type":"4"}},{"id":1228922,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Science & Tech."}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-04T21:55:25.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option shall vest and become exercisable on March 3, 2026, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date."}],"balance_after":145000,"derivative":{"exercise_price":1.67,"expiration_date":"2035-03-02","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0000950170-25-032326","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025032326/ownership.xml","form_type":"4"}},{"id":1480137,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T21:02:51.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 substantially equal monthly installments commencing on July 13, 2024, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the \"Plan\") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan)."}],"balance_after":5000,"derivative":{"exercise_price":10.5,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001789769-24-000066","document":"wk-form4_1718312563.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789769/000178976924000066/wk-form4_1718312563.xml","form_type":"4"}},{"id":1603295,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-04T22:28:16.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option shall vest and become exercisable on March 1, 2025, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date."}],"balance_after":130000,"derivative":{"exercise_price":23.97,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0000950170-24-024978","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017024024978/ownership.xml","form_type":"4"}},{"id":1675298,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-19T23:30:06.000Z","date":"2024-01-19","kind":"exercise","planned":false,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests over four years, with 25% vested on October 11, 2019, and the remaining shares vesting in 12 equal quarterly installments thereafter."}],"balance_after":100756,"derivative":{"exercise_price":1.01,"expiration_date":"2028-10-28","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000950170-24-005888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017024005888/ownership.xml","form_type":"4"}},{"id":1675297,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-19T23:30:06.000Z","date":"2024-01-19","kind":"sale","planned":false,"acquired":false,"shares":700,"price":20.3266,"value":14228.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.24 - $20.35. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000950170-24-005888","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017024005888/ownership.xml","form_type":"4"}},{"id":1675296,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-19T23:30:06.000Z","date":"2024-01-19","kind":"sale","planned":false,"acquired":false,"shares":10300,"price":19.535,"value":201210.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.16 - $20.10. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20700,"source":{"system":"sec-edgar","filing":"0000950170-24-005888","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017024005888/ownership.xml","form_type":"4"}},{"id":1675295,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-19T23:30:06.000Z","date":"2024-01-19","kind":"exercise","planned":false,"acquired":true,"shares":11000,"price":1.01,"value":11110.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."}],"balance_after":31000,"source":{"system":"sec-edgar","filing":"0000950170-24-005888","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017024005888/ownership.xml","form_type":"4"}},{"id":1681339,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-11T01:10:49.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date."}],"balance_after":1500,"derivative":{"exercise_price":11.18,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001789769-24-000011","document":"wk-form4_1704935440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789769/000178976924000011/wk-form4_1704935440.xml","form_type":"4"}},{"id":1704961,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-20T01:37:37.000Z","date":"2023-12-19","kind":"exercise","planned":false,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests over four years, with 25% vested on October 11, 2019, and the remaining shares vesting in 12 equal quarterly installments thereafter."}],"balance_after":111756,"derivative":{"exercise_price":1.01,"expiration_date":"2028-10-28","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000950170-23-071689","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023071689/ownership.xml","form_type":"4"}},{"id":1704960,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-20T01:37:37.000Z","date":"2023-12-19","kind":"sale","planned":false,"acquired":false,"shares":3132,"price":22.2201,"value":69593.3532,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.06 - $22.40. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000950170-23-071689","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023071689/ownership.xml","form_type":"4"}},{"id":1704959,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-20T01:37:37.000Z","date":"2023-12-19","kind":"sale","planned":false,"acquired":false,"shares":7868,"price":21.7585,"value":171195.878,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.05 - $22.04. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":23132,"source":{"system":"sec-edgar","filing":"0000950170-23-071689","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023071689/ownership.xml","form_type":"4"}},{"id":1704958,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-20T01:37:37.000Z","date":"2023-12-19","kind":"exercise","planned":false,"acquired":true,"shares":11000,"price":1.01,"value":11110.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."}],"balance_after":31000,"source":{"system":"sec-edgar","filing":"0000950170-23-071689","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023071689/ownership.xml","form_type":"4"}},{"id":1732781,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-21T21:30:32.000Z","date":"2023-11-20","kind":"exercise","planned":false,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests over four years, with 25% vested on October 11, 2019, and the remaining shares vesting in 12 equal quarterly installments thereafter."}],"balance_after":122756,"derivative":{"exercise_price":1.01,"expiration_date":"2028-10-28","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000950170-23-065521","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023065521/ownership.xml","form_type":"4"}},{"id":1732780,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-11-21T21:30:32.000Z","date":"2023-11-20","kind":"sale","planned":false,"acquired":false,"shares":7458,"price":18.0216,"value":134405.0928,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.90 - $18.24. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000950170-23-065521","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023065521/ownership.xml","form_type":"4"}},{"id":1732779,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-11-21T21:30:32.000Z","date":"2023-11-20","kind":"sale","planned":false,"acquired":false,"shares":3542,"price":17.3937,"value":61608.4854,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.90 - $17.89. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":27458,"source":{"system":"sec-edgar","filing":"0000950170-23-065521","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023065521/ownership.xml","form_type":"4"}},{"id":1732778,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-11-21T21:30:32.000Z","date":"2023-11-20","kind":"exercise","planned":false,"acquired":true,"shares":11000,"price":1.01,"value":11110.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."}],"balance_after":31000,"source":{"system":"sec-edgar","filing":"0000950170-23-065521","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023065521/ownership.xml","form_type":"4"}},{"id":1757487,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-19T23:40:05.000Z","date":"2023-10-19","kind":"exercise","planned":false,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests over four years, with 25% vested on October 11, 2019, and the remaining shares vesting in 12 equal quarterly installments thereafter."}],"balance_after":133756,"derivative":{"exercise_price":1.01,"expiration_date":"2028-10-28","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000950170-23-054234","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023054234/ownership.xml","form_type":"4"}},{"id":1757486,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-10-19T23:40:05.000Z","date":"2023-10-19","kind":"sale","planned":false,"acquired":false,"shares":408,"price":14.276,"value":5824.608,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.15 - $14.54. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000950170-23-054234","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023054234/ownership.xml","form_type":"4"}},{"id":1757485,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-10-19T23:40:05.000Z","date":"2023-10-19","kind":"sale","planned":false,"acquired":false,"shares":10592,"price":13.321,"value":141096.032,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.01 - $13.59. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20408,"source":{"system":"sec-edgar","filing":"0000950170-23-054234","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023054234/ownership.xml","form_type":"4"}},{"id":1757484,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-10-19T23:40:05.000Z","date":"2023-10-19","kind":"exercise","planned":false,"acquired":true,"shares":11000,"price":1.01,"value":11110.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."}],"balance_after":31000,"source":{"system":"sec-edgar","filing":"0000950170-23-054234","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023054234/ownership.xml","form_type":"4"}},{"id":1776269,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-20T20:30:04.000Z","date":"2023-09-19","kind":"exercise","planned":true,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests over four years, with 25% vested on October 11, 2019, and the remaining shares vesting in 12 equal quarterly installments thereafter."}],"balance_after":144756,"derivative":{"exercise_price":1.01,"expiration_date":"2028-10-28","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000950170-23-049005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023049005/ownership.xml","form_type":"4"}},{"id":1776268,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-09-20T20:30:04.000Z","date":"2023-09-19","kind":"sale","planned":true,"acquired":false,"shares":700,"price":18.5,"value":12950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.29 - $18.68. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000950170-23-049005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023049005/ownership.xml","form_type":"4"}},{"id":1776267,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-09-20T20:30:04.000Z","date":"2023-09-19","kind":"sale","planned":true,"acquired":false,"shares":10300,"price":17.5019,"value":180269.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.17 - $18.11. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20700,"source":{"system":"sec-edgar","filing":"0000950170-23-049005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023049005/ownership.xml","form_type":"4"}},{"id":1776266,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-09-20T20:30:04.000Z","date":"2023-09-19","kind":"exercise","planned":true,"acquired":true,"shares":11000,"price":1.01,"value":11110.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."}],"balance_after":31000,"source":{"system":"sec-edgar","filing":"0000950170-23-049005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023049005/ownership.xml","form_type":"4"}},{"id":1799724,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-22T20:30:33.000Z","date":"2023-08-21","kind":"exercise","planned":true,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests over four years, with 25% vested on October 11, 2019, and the remaining shares vesting in 12 equal quarterly installments thereafter."}],"balance_after":155756,"derivative":{"exercise_price":1.01,"expiration_date":"2028-10-28","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000950170-23-043920","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023043920/ownership.xml","form_type":"4"}},{"id":1799723,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-08-22T20:30:33.000Z","date":"2023-08-21","kind":"sale","planned":true,"acquired":false,"shares":300,"price":13.8233,"value":4146.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.7800 - $14.7799. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000950170-23-043920","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023043920/ownership.xml","form_type":"4"}},{"id":1799722,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-08-22T20:30:33.000Z","date":"2023-08-21","kind":"sale","planned":true,"acquired":false,"shares":10700,"price":13.4052,"value":143435.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.7800 - $13.7799. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20300,"source":{"system":"sec-edgar","filing":"0000950170-23-043920","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023043920/ownership.xml","form_type":"4"}},{"id":1799721,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-08-22T20:30:33.000Z","date":"2023-08-21","kind":"exercise","planned":true,"acquired":true,"shares":11000,"price":1.01,"value":11110.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."}],"balance_after":31000,"source":{"system":"sec-edgar","filing":"0000950170-23-043920","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017023043920/ownership.xml","form_type":"4"}},{"id":1826917,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T00:37:36.000Z","date":"2023-07-19","kind":"exercise","planned":true,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests over four years, with 25% vested on October 11, 2019, and the remaining shares vesting in 12 equal quarterly installments thereafter."}],"balance_after":166756,"derivative":{"exercise_price":1.01,"expiration_date":"2028-10-28","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000899243-23-017452","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924323017452/doc4.xml","form_type":"4"}},{"id":1826916,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-07-20T00:37:36.000Z","date":"2023-07-19","kind":"sale","planned":true,"acquired":false,"shares":2815,"price":14.2604,"value":40143.026,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.17 - $14.42. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000899243-23-017452","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924323017452/doc4.xml","form_type":"4"}},{"id":1826915,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-07-20T00:37:36.000Z","date":"2023-07-19","kind":"sale","planned":true,"acquired":false,"shares":8185,"price":13.6688,"value":111879.128,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.17 - $14.14. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":22815,"source":{"system":"sec-edgar","filing":"0000899243-23-017452","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924323017452/doc4.xml","form_type":"4"}},{"id":1826914,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-07-20T00:37:36.000Z","date":"2023-07-19","kind":"exercise","planned":true,"acquired":true,"shares":11000,"price":1.01,"value":11110.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."}],"balance_after":31000,"source":{"system":"sec-edgar","filing":"0000899243-23-017452","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924323017452/doc4.xml","form_type":"4"}},{"id":1847918,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-21T20:38:52.000Z","date":"2023-06-20","kind":"exercise","planned":true,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests over four years, with 25% vested on October 11, 2019, and the remaining shares vesting in 12 equal quarterly installments thereafter."}],"balance_after":177756,"derivative":{"exercise_price":1.01,"expiration_date":"2028-10-28","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000899243-23-016147","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924323016147/doc4.xml","form_type":"4"}},{"id":1847917,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-06-21T20:38:52.000Z","date":"2023-06-20","kind":"sale","planned":true,"acquired":false,"shares":11000,"price":12.9932,"value":142925.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.36 - $13.30. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000899243-23-016147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924323016147/doc4.xml","form_type":"4"}},{"id":1847916,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-06-21T20:38:52.000Z","date":"2023-06-20","kind":"exercise","planned":true,"acquired":true,"shares":11000,"price":1.01,"value":11110.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."}],"balance_after":31000,"source":{"system":"sec-edgar","filing":"0000899243-23-016147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924323016147/doc4.xml","form_type":"4"}},{"id":1884746,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-20T00:10:13.000Z","date":"2023-05-19","kind":"exercise","planned":true,"acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests over four years, with 25% vested on October 11, 2019, and the remaining shares vesting in 12 equal quarterly installments thereafter."}],"balance_after":188756,"derivative":{"exercise_price":1.01,"expiration_date":"2028-10-28","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0000899243-23-013455","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924323013455/doc4.xml","form_type":"4"}},{"id":1884745,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-05-20T00:10:13.000Z","date":"2023-05-19","kind":"sale","planned":true,"acquired":false,"shares":22000,"price":11.8106,"value":259833.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.58 - $12.27. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000899243-23-013455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924323013455/doc4.xml","form_type":"4"}},{"id":1884744,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-05-20T00:10:13.000Z","date":"2023-05-19","kind":"exercise","planned":true,"acquired":true,"shares":22000,"price":1.01,"value":22220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person."}],"balance_after":42000,"source":{"system":"sec-edgar","filing":"0000899243-23-013455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924323013455/doc4.xml","form_type":"4"}},{"id":2043783,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-28T01:50:23.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":176000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option shall vest and become exercisable on January 18, 2024, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date."}],"balance_after":176000,"derivative":{"exercise_price":11.09,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":176000},"source":{"system":"sec-edgar","filing":"0000899243-23-002910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924323002910/doc4.xml","form_type":"4"}},{"id":2135610,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-10-19T01:50:36.000Z","date":"2022-10-18","kind":"purchase","acquired":true,"shares":20000,"price":0.9947,"value":19894.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased at prices ranging from $0.9894 to $0.9947, inclusive. The reporting person has provided to the Issuer, and undertakes to provide any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000899243-22-033780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924322033780/doc4.xml","form_type":"4"}},{"id":2256343,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-05-25T22:01:30.000Z","date":"2022-05-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments commencing on June 20, 2022, subject to the Report Person's continued service as a director through the vesting date."}],"balance_after":30000,"derivative":{"exercise_price":7.27,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001789769-22-000049","document":"wf-form4_165351607627422.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789769/000178976922000049/wf-form4_165351607627422.xml","form_type":"4"}},{"id":2432384,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T00:53:40.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option shall vest and become exercisable on January 18, 2023, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date."}],"balance_after":160000,"derivative":{"exercise_price":3.21,"expiration_date":"2032-01-17","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0000899243-22-002508","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924322002508/doc4.xml","form_type":"4"}},{"id":2775880,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-23T00:47:06.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 36 equal monthly installments commencing on April 18, 2021, subject to the Report Person's continued service as a director through the vesting date."}],"balance_after":52000,"derivative":{"exercise_price":20,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001209191-21-022470","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789769/000120919121022470/doc4.xml","form_type":"4"}},{"id":2820809,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Science & Technology"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-03T02:46:19.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over four years, with 25% vesting on March 1, 2022 and the remaining shares vesting in 12 equal quarterly installments thereafter."}],"balance_after":125000,"derivative":{"exercise_price":11.47,"expiration_date":"2031-02-28","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-21-009234","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924321009234/doc4.xml","form_type":"4"}},{"id":3387239,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Science & Technology"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-29T00:43:39.000Z","date":"2019-10-24","kind":"grant","acquired":true,"shares":29908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over four years, with 25% vesting on October 24, 2020, and the remaining shares vesting in 12 equal quarterly installments thereafter."}],"balance_after":29908,"derivative":{"exercise_price":11,"expiration_date":"2029-10-23","underlying":"Common Stock","underlying_shares":29908},"source":{"system":"sec-edgar","filing":"0000899243-19-026020","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924319026020/doc4.xml","form_type":"4"}}]}